Paralemmin interacts with D3 dopamine receptors: Implications for membrane localization and cAMP signaling

Archives of Biochemistry and Biophysics

Volumn 446, Issue 1, 2006, Pages 60-68

  Basile, Maria ^a   Lin, Ridwan ^a   Kabbani, Nadine ^a   Karpa, Kelly ^a   Kilimann, Manfred ^b   Simpson, Ian ^a   Kester, Mark ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Brain; cAMP; Dopamine receptors; G proteins; Hippocampus; Paralemmin; Signaling

Indexed keywords

ADENYLATE CYCLASE; AMINO ACID; CYCLIC AMP; DOPAMINE RECEPTOR; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; PARALEMMIN; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL;

ADENYLATE CYCLASE; AMINO ACIDS; ANIMALS; BIOTINYLATION; BRAIN; CELLS, CULTURED; CEREBELLUM; CYCLIC AMP; FORSKOLIN; GLUTATHIONE TRANSFERASE; HIPPOCAMPUS; ISOPROTERENOL; MEMBRANE PROTEINS; MUTATION; NEUROGLIA; NEURONS; PHOSPHOPROTEINS; RATS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; SIGNAL TRANSDUCTION;

EID: 31544483359     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2005.10.027     Document Type: Article

References (21)

1. M.J. Kaufman, and B.K. Madras Synapse 9 1991 43 49
2. J. Maj, M. Dziedzicka-Wasylewska, R. Rogoz, and Z. Rogoz Eur. J. Pharmacol. 351 1998 31 37
3. C. Schmauss, V. Haroutunian, K.L. Davis, and M. Davidson Neurobiology 90 1993 8942 8946
4. G.F. Koob, and F.E. Bloom Science 242 1998 715 723
5. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Physiol. Rev. 78 1998 189 225
6. J. Obadiah, T. Avidor-Reiss, C. Simone-Fishburn, S. Carmon, M. Bayewitch, Z. Vogel, S. Fuchs, and B. Levavi-Sivan Cell Mol. Neurobiol. 19 1999 653 664
7. B.M. Muller, U. Kistner, S. Kindler, W.J. Chung, S. Kuhlendahl, S.D. Fenster, L.F. Lau, R.W. Veh, R.L. Huganir, E.D. Gundelfinger, and C.C. Garner Neuron 17 1996 255 265
8. R. Lin, K. Karpa, N. Kabbani, P. Goldman-Rakic, and R. Levenson Proc. Natl. Acad. Sci. USA 98 2001 5258 5263
9. F. Donelson-Smith, G.S. Oxford, and S.L. Milgram J. Biol. Chem. 274 1999 19894 19900
10. N. Kabbani, L. Negessey, R. Lin, P. Goldman-Rakic, and R. Levenson J. Neurosci. 22 2002 8476 8486
11. C. Kutzleb, G. Sanders, R. Yamamoto, X. Wang, B. Lichte, E. Petrasch-Parwez, and M.W. Kilimann J. Cell Biol. 143 1998 795 813
12. C. Gauthier-Campbell, D.S. Bredt, T.H. Murphy, and A.D. El-Husseini Mol. Biol. Cell 15 2004 2205 2217
13. R.H. Schiestl, and R.D. Gietz Curr. Genet. 16 1989 339 346
14. K.D. Karpa, R. Lin, N. Kabbani, and R. Levenson Mol. Pharmacol. 58 2000 677 683
15. K.M. Kim, K.J. Valenzano, S.R. Robinson, W.D. Yao, L.S. Barak, and M.G. Caron J. Biol. Chem. 276 2001 37409 37414
16. A.V. Binda, N. Kabbani, R. Lin, and R. Levenson Mol. Pharmacol. 62 2002 507 513
17. A.V. Hubberstey, and E.P. Mottillo FASEB J. 16 2002 487 499
18. S.H. Ghil, B.J. Kim, Y.D. Lee, and H. Suh-Kim J. Neurochem. 74 2000 151 158
19. B.G. Burwinkel, G. Miglierini, D.E. Jenne, D.J. Gilbert, N.G. Copeland, N.A. Jenkins, H.Z. Ring, U. Francke, and M.W. Kilimann Genomics 49 1998 462 466
20. B. Levant Am. Soc. Pharmacol. Exp. Ther. 49 1997 231 252
21. S.B. Glickstein, P.R. Hof, and C. Schmauss J. Neurosci. 22 2002 5619 5629